Tanke Biosciences Stock Operating Margin
TNBI Stock | USD 0.02 0.01 33.33% |
Tanke Biosciences fundamentals help investors to digest information that contributes to Tanke Biosciences' financial success or failures. It also enables traders to predict the movement of Tanke Pink Sheet. The fundamental analysis module provides a way to measure Tanke Biosciences' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Tanke Biosciences pink sheet.
Tanke |
Tanke Biosciences Company Operating Margin Analysis
Tanke Biosciences' Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current Tanke Biosciences Operating Margin | (0) % |
Most of Tanke Biosciences' fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Tanke Biosciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
Competition |
Based on the recorded statements, Tanke Biosciences has an Operating Margin of -0.0025%. This is 100.01% lower than that of the Financial Services sector and significantly lower than that of the Shell Companies industry. The operating margin for all United States stocks is 99.95% lower than that of the firm.
Did you try this?
Run Financial Widgets Now
Financial WidgetsEasily integrated Macroaxis content with over 30 different plug-and-play financial widgets |
All Next | Launch Module |
Tanke Fundamentals
Return On Equity | -0.1 | |||
Return On Asset | -0.0012 | |||
Profit Margin | (0.07) % | |||
Operating Margin | (0) % | |||
Current Valuation | 4.56 M | |||
Shares Outstanding | 13.32 M | |||
Price To Earning | (0.08) X | |||
Price To Book | 0.02 X | |||
Price To Sales | 0.09 X | |||
Revenue | 28.56 M | |||
Gross Profit | 9.94 M | |||
EBITDA | 804.29 K | |||
Net Income | (210.25 K) | |||
Cash And Equivalents | 5.09 M | |||
Cash Per Share | 0.38 X | |||
Debt To Equity | 0.60 % | |||
Current Ratio | 1.61 X | |||
Book Value Per Share | 1.17 X | |||
Cash Flow From Operations | (1.18 M) | |||
Earnings Per Share | (0.12) X | |||
Number Of Employees | 130 | |||
Beta | 0.96 | |||
Market Capitalization | 2 M | |||
Total Asset | 28.85 M | |||
Retained Earnings | 1.62 M | |||
Working Capital | 7.46 M | |||
Current Asset | 19.7 M | |||
Current Liabilities | 12.23 M | |||
Net Asset | 28.85 M |
About Tanke Biosciences Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Tanke Biosciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Tanke Biosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Tanke Biosciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Tanke Pink Sheet
Tanke Biosciences financial ratios help investors to determine whether Tanke Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Tanke with respect to the benefits of owning Tanke Biosciences security.